Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7490 | 1282 | 40.0 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD59 | Author keyword | 62 | 40% | 9% | 121 |
2 | CRRY | Author keyword | 50 | 86% | 2% | 25 |
3 | CD55 | Author keyword | 32 | 43% | 4% | 57 |
4 | DECAY ACCELERATING FACTOR | Author keyword | 27 | 43% | 4% | 47 |
5 | CD46 | Author keyword | 24 | 34% | 5% | 59 |
6 | MEMBRANE COFACTOR PROTEIN MCP CD46 | Author keyword | 21 | 90% | 1% | 9 |
7 | COMPLEMENT BIOL GRP | Address | 17 | 47% | 2% | 27 |
8 | COMPLEMENT REGULATORY PROTEINS | Author keyword | 15 | 40% | 2% | 30 |
9 | COMPLEMENT REGULATORY PROTEIN | Author keyword | 13 | 49% | 1% | 19 |
10 | HRF20 | Author keyword | 11 | 100% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD59 | 62 | 40% | 9% | 121 | Search CD59 | Search CD59 |
2 | CRRY | 50 | 86% | 2% | 25 | Search CRRY | Search CRRY |
3 | CD55 | 32 | 43% | 4% | 57 | Search CD55 | Search CD55 |
4 | DECAY ACCELERATING FACTOR | 27 | 43% | 4% | 47 | Search DECAY+ACCELERATING+FACTOR | Search DECAY+ACCELERATING+FACTOR |
5 | CD46 | 24 | 34% | 5% | 59 | Search CD46 | Search CD46 |
6 | MEMBRANE COFACTOR PROTEIN MCP CD46 | 21 | 90% | 1% | 9 | Search MEMBRANE+COFACTOR+PROTEIN+MCP++CD46 | Search MEMBRANE+COFACTOR+PROTEIN+MCP++CD46 |
7 | COMPLEMENT REGULATORY PROTEINS | 15 | 40% | 2% | 30 | Search COMPLEMENT+REGULATORY+PROTEINS | Search COMPLEMENT+REGULATORY+PROTEINS |
8 | COMPLEMENT REGULATORY PROTEIN | 13 | 49% | 1% | 19 | Search COMPLEMENT+REGULATORY+PROTEIN | Search COMPLEMENT+REGULATORY+PROTEIN |
9 | HRF20 | 11 | 100% | 0% | 6 | Search HRF20 | Search HRF20 |
10 | COMPLEMENT REGULATORS | 8 | 42% | 1% | 15 | Search COMPLEMENT+REGULATORS | Search COMPLEMENT+REGULATORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR DAF | 138 | 63% | 11% | 137 |
2 | DECAY ACCELERATING FACTOR | 99 | 22% | 31% | 400 |
3 | MEMBRANE COFACTOR PROTEIN | 89 | 36% | 16% | 203 |
4 | C 3 CONVERTASES | 62 | 74% | 4% | 46 |
5 | MCP | 56 | 53% | 6% | 74 |
6 | MOUSE CRRY P65 | 44 | 88% | 2% | 21 |
7 | HOMOLOGOUS COMPLEMENT | 39 | 59% | 3% | 44 |
8 | ATTACK COMPLEX | 35 | 42% | 5% | 65 |
9 | COFACTOR PROTEIN | 35 | 59% | 3% | 39 |
10 | INHIBITOR PROTECTIN CD59 | 31 | 92% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Membrane complement regulatory proteins | 2006 | 137 | 112 | 51% |
Immune evasion of tumor cells using membrane-bound complement regulatory proteins | 1999 | 131 | 73 | 56% |
Holding T cells in check - a new role for complement regulators? | 2006 | 69 | 48 | 69% |
T-cell regulation: with complements from innate immunity | 2007 | 157 | 92 | 25% |
Control of the complement system | 1996 | 295 | 359 | 38% |
Complement function in mAb-mediated cancer immunotherapy | 2004 | 146 | 61 | 38% |
Complement in Cancer and Cancer Immunotherapy | 2011 | 22 | 132 | 38% |
Regulation of the complement membrane attack pathway | 1999 | 125 | 182 | 40% |
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro | 2010 | 20 | 54 | 56% |
CD46 processing: A means of expression | 2012 | 8 | 103 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPLEMENT BIOL GRP | 17 | 47% | 2.1% | 27 |
2 | MED MED SCI MED 1 | 8 | 75% | 0.5% | 6 |
3 | SURG FUNCT REGULAT | 2 | 44% | 0.3% | 4 |
4 | ORGAN TRANSPLANTAT E9 | 1 | 38% | 0.2% | 3 |
5 | CRIMSON BIOSPECIMEN CORE | 1 | 100% | 0.2% | 2 |
6 | ENVIRONM PHARMACOL | 1 | 40% | 0.2% | 2 |
7 | CANC MINIST EDUC LIFE SCI | 1 | 50% | 0.1% | 1 |
8 | CLIN IMMUNE | 1 | 50% | 0.1% | 1 |
9 | CONTROL DIS AQUAT ANIM | 1 | 50% | 0.1% | 1 |
10 | CR UK CLIN ONCOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242332 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA//PNH//PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
2 | 0.0000187443 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
3 | 0.0000157895 | COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1 |
4 | 0.0000152059 | ATYPICAL HEMOLYTIC UREMIC SYNDROME//FACTOR H//C3 GLOMERULOPATHY |
5 | 0.0000150799 | C8 ALPHA//C8 GAMMA//PROPERDIN DEFICIENCY |
6 | 0.0000134865 | RGC 32//RESPONSE GENE TO COMPLEMENT 32//BIIG |
7 | 0.0000109204 | CD21//COMPLEMENT RECEPTOR 2//CR2 |
8 | 0.0000104993 | COMPSTATIN//COBRA VENOM FACTOR//STELLAR CHANCE S 401 |
9 | 0.0000080523 | C5A//C5A RECEPTOR//C5AR |
10 | 0.0000080471 | ACUTE MYOCARDIAL DISEASE//THANATOCHEMISTRY//COMPLEMENT C9 |